Filgen Injection 30 MU contains Filgrastim, a granulocyte colony-stimulating factor (G-CSF) that helps the body produce more white blood cells. 

It is commonly prescribed for patients undergoing chemotherapy or bone marrow transplantation, helping to prevent and treat neutropenia (low white blood cell count). 

This injection strengthens immunity and reduces infection risk during cancer treatment or after major medical therapy.

Uses

Treats and prevents neutropenia caused by chemotherapy or radiation therapy.

Helps in recovery of white blood cells after bone marrow or stem cell transplant.

Boosts immune defense in patients receiving strong anti-cancer treatments.

Sometimes used to mobilize stem cells before bone marrow donation.

Supports patients with severe chronic neutropenia or congenital low WBC counts.

Dosage & Administration

Route: Administered subcutaneously (under the skin) or intravenously (IV) by a healthcare professional.

Dosage: Depends on body weight, medical condition, and response to treatment.

Typically given once daily until white blood cell levels return to normal.

Store between 2°C and 8°C. Do not freeze.

Always follow your doctor’s or nurse’s instructions during administration.

Benefits

Accelerates the recovery of white blood cell count after chemotherapy.

Reduces risk of infection, fever, and antibiotic use in cancer patients.

Enhances the body’s natural defense system during cancer therapy.

Improves treatment continuity by preventing chemotherapy delays.

Aids in faster recovery and boosts immune strength.

Precautions

Regularly monitor blood counts and liver function during treatment.

Not to be used in patients with myeloid malignancies without a doctor’s advice.

Inform your doctor if you experience bone pain, fever, or allergic reaction.

Use with caution during pregnancy and breastfeeding.